Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Sensory and Autonomic Neuropathies”

188 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 188 results

Early research (Phase 1)Ended earlyNCT00996892
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Pictilisib in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Genentech, Inc. 178
Not applicableUnknownNCT05750693
What this trial is testing

PIK3CA in HER2+ BC and pCR Trial

Who this might be right for
HER2-positive Breast Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 58
Testing effectiveness (Phase 2)Study completedNCT05054725
What this trial is testing

Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies

Who this might be right for
Non-Small Cell Lung Cancer
Revolution Medicines, Inc. 47
Large-scale testing (Phase 3)Study completedNCT00830063
What this trial is testing

Tanezumab In Osteoarthritis Of The Knee (2)

Who this might be right for
ArthritisOsteoarthritis
Pfizer 832
Not applicableLooking for participantsNCT03920774
What this trial is testing

The Natural History of Familial Dysautonomia

Who this might be right for
Familial Dysautonomia (Riley-Day Syndrome)Hereditary Sensory and Autonomic NeuropathiesHereditary Sensory and Autonomic Neuropathy 3
NYU Langone Health 400
Not applicableUnknownNCT06267066
What this trial is testing

Fractional Carbon Dioxide Laser: A Novel Therapeutic Option for Lichen Simplex Chronicus

Who this might be right for
Lichen Simplex Chronicus
Cairo University 60
Large-scale testing (Phase 3)UnknownNCT05660447
What this trial is testing

A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR

Who this might be right for
Rhegmatogenous Retinal DetachmentProliferative Vitreoretinopathy
Wills Eye 80
Testing effectiveness (Phase 2)Study completedNCT03962114
What this trial is testing

Effects of Vitamin B3 in Patients With Ataxia Telangiectasia

Who this might be right for
Ataxia TelangiectasiaATM Gene Mutation
Radboud University Medical Center 24
Early research (Phase 1)Study completedNCT03309150
What this trial is testing

ATRi Transition Rollover Study

Who this might be right for
Advanced Stage Solid Tumors
Merck KGaA, Darmstadt, Germany 1
Early research (Phase 1)Study completedNCT01449370
What this trial is testing

Dose Escalation Study of TAK-117 (MLN1117) in Subjects With Advanced Cancer

Who this might be right for
Metastatic Solid Tumors
Millennium Pharmaceuticals, Inc. 125
Not applicableStudy completedNCT01632605
What this trial is testing

The Vienna RAP Pilot Study

Who this might be right for
ADPKD
Medical University of Vienna 8
Testing effectiveness (Phase 2)Ended earlyNCT02644122
What this trial is testing

SF1126 in Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and/or PI-3 Kinase Pathway Genes

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
Ezra Cohen 1
Testing effectiveness (Phase 2)UnknownNCT04163419
What this trial is testing

Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis

Who this might be right for
SchwannomatosisPain
Massachusetts General Hospital 9
Testing effectiveness (Phase 2)WithdrawnNCT01960023
What this trial is testing

Safety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
NSABP Foundation Inc
Not applicableStudy completedNCT04285723
What this trial is testing

Retrospective Chart Review Study of Patients With PIK3CA-Related Overgrowth Spectrum Who Have Received Alpelisib

Who this might be right for
PIK3CA-Related Overgrowth Spectrum (PROS)
Novartis Pharmaceuticals 57
Not applicableStudy completedNCT03948997
What this trial is testing

The Role of Angiogenesis-related Pathways in the Development of Port Wine Stains

Who this might be right for
Port Wine Stain
xjpfW 80
Large-scale testing (Phase 3)Ended earlyNCT02204982
What this trial is testing

Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
SecuraBio 13
Not applicableStudy completedNCT05751174
What this trial is testing

Determination of Nerve Growth Factor (NGF) Expression in Pediatric Patients With Severe Burns: a Pilot Study

Who this might be right for
Burns
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 12
Large-scale testing (Phase 3)Ended earlyNCT02467582
What this trial is testing

Adjuvant Aspirin Treatment for Colon Cancer Patients

Who this might be right for
Colon Cancer
Swiss Cancer Institute 1,040
Testing effectiveness (Phase 2)Study completedNCT04997902
What this trial is testing

Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

Who this might be right for
HNSCC
Kura Oncology, Inc. 45
Next Page